Kwiatkowski; Nicholas Paul
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kwiatkowski; Nicholas Paul.The latest application filed is for "inhibitors of cyclin-dependent kinase 7 and uses thereof".
Company Profile
3.16.29
- Kwiatkowski; Nicholas Paul - Brookline MA
- Kwiatkowski; Nicholas Paul - Auburn MA
Patent Activity
| Patent | Date |
|---|---|
| Inhibitors Of Cyclin-dependent Kinase 7 And Uses Thereof App 20220281874 - Zhang; Tinghu ; et al. | 2022-09-08 |
| Inhibitors Of Cyclin-dependent Kinases App 20220242865 - Gray; Nathanael S. ; et al. | 2022-08-04 |
| Degraders Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20220227734 - Che; Jianwei ; et al. | 2022-07-21 |
| Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20220213067 - Gray; Nathanael S. ; et al. | 2022-07-07 |
| Inhibitors of cyclin-dependent kinases Grant 11,325,910 - Gray , et al. May 10, 2 | 2022-05-10 |
| Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof Grant 11,306,070 - Gray , et al. April 19, 2 | 2022-04-19 |
| Inhibitors Of Cyclin-dependent Kinase 7 And Uses Thereof App 20220089611 - Gray; Nathanael S. ; et al. | 2022-03-24 |
| Inhibitors Of Cyclin-dependent Kinases App 20220055998 - Gray; Nathanael S. ; et al. | 2022-02-24 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20220024929 - Gray; Nathanael S. ; et al. | 2022-01-27 |
| Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20210317105 - Gray; Nathanael S. ; et al. | 2021-10-14 |
| Inhibitors of cyclin-dependent kinases Grant 11,142,507 - Gray , et al. October 12, 2 | 2021-10-12 |
| Inhibitors Of Cyclin-dependent Kinases App 20210261551 - Gray; Nathanael S. ; et al. | 2021-08-26 |
| Compounds For Treating Dengue Virus Infections And Other Infections App 20210230101 - Yang; Priscilla L. ; et al. | 2021-07-29 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20210115051 - Gray; Nathanael S. ; et al. | 2021-04-22 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,870,651 - Gray , et al. December 22, 2 | 2020-12-22 |
| Compounds For Treating Dengue Virus Infection And Other Viral Infections App 20200360381 - Yang; Priscilla L. ; et al. | 2020-11-19 |
| Inhibitors Of Cyclin-dependent Kinase 12 (cdk12) And Uses Thereof App 20200361906 - Gray; Nathanael S. ; et al. | 2020-11-19 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,787,436 - Gray , et al. September 29, 2 | 2020-09-29 |
| Inhibitors Of Cyclin-dependent Kinases App 20200277292 - Gray; Nathanael S. ; et al. | 2020-09-03 |
| Inhibitors Of Cyclin-dependent Kinases App 20200172499 - Gray; Nathanael S. ; et al. | 2020-06-04 |
| Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 10,570,154 - Gray , et al. Feb | 2020-02-25 |
| Inhibitors of cyclin-dependent kinases Grant 10,550,121 - Gray , et al. Fe | 2020-02-04 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20200017475 - Gray; Nathanael ; et al. | 2020-01-16 |
| Inhibitors Of Cyclin-dependent Kinases App 20190315747 - Gray; Nathanael S. ; et al. | 2019-10-17 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190100511 - Gray; Nathanael ; et al. | 2019-04-04 |
| Inhibitors Of Cyclindependent Kinase 7 (cdk7) App 20190055248 - Gray; Nathanael S. ; et al. | 2019-02-21 |
| Treatment of protein degradation disorders Grant 10,172,905 - Anderson , et al. J | 2019-01-08 |
| Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20180362545 - Gray; Nathanael S. ; et al. | 2018-12-20 |
| Inhibitors Of Cyclin-dependent Kinases App 20180362483 - Gray; Nathanael S. ; et al. | 2018-12-20 |
| Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,112,927 - Gray , et al. October 30, 2 | 2018-10-30 |
| Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 10,081,639 - Gray , et al. September 25, 2 | 2018-09-25 |
| Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20170260208 - Gray; Nathanael S. ; et al. | 2017-09-14 |
| Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 9,701,683 - Gray , et al. July 11, 2 | 2017-07-11 |
| Treatment of protein degradation disorders Grant 9,572,854 - Anderson , et al. February 21, 2 | 2017-02-21 |
| Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20160347755 - Gray; Nathanael S. ; et al. | 2016-12-01 |
| Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Grant 9,464,091 - Gray , et al. October 11, 2 | 2016-10-11 |
| Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20160122357 - Gray; Nathanael S. ; et al. | 2016-05-05 |
| Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20160122323 - Gray; Nathanael ; et al. | 2016-05-05 |
| Treatment Of Protein Degradation Disorders App 20160051619 - Anderson; Kenneth C. ; et al. | 2016-02-25 |
| Treatment of protein degradation disorders Grant 8,999,289 - Anderson , et al. April 7, 2 | 2015-04-07 |
| Histone deacetylase and tubulin deacetylase inhibitors Grant 8,304,451 - Mazitschek , et al. November 6, 2 | 2012-11-06 |
| Pyrimido-diazepinone Kinase Scaffold Compounds And Methods Of Treating Disorders App 20120040961 - Gray; Nathanael S. ; et al. | 2012-02-16 |
| Histone Deacetylase and Tubulin Deacetylase Inhibitors App 20090209590 - Mazitschek; Ralph ; et al. | 2009-08-20 |
| Treatment of protein degradation disorders App 20060239909 - Anderson; Kenneth C. ; et al. | 2006-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 